Nathan R. Foster

机构：Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic in Florida · ORCID：0000-0002-2874-1295

发表论文 426 篇 · 总被引 9182 次 · h-index 47

代表论文

De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial (2025 · The Lancet Oncology · 被引 23)
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian Cancer (2025 · American Journal of Clinical Oncology · 被引 3)
Randomized, Double-Blind, Placebo-Controlled Trial of Meriva (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis (2026 · Cancer Prevention Research · 被引 2)
Epidemiologic Method Review at Scale: Assessing Charlson Comorbidity Versioning Using a Large Language Model (2025 · medRxiv · 被引 1)
Supplementary Figure S4 from Randomized, Double-Blind, Placebo-Controlled Trial of Meriva (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis (2026)
Supplementary Table S4 from Randomized, Double-Blind, Placebo-Controlled Trial of Meriva (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis (2026)